[en] PLAG1, a novel developmentally regulated C2H2 zinc finger gene, is consistently rearranged and overexpressed in pleomorphic adenomas of the salivary glands with 8q12 translocations. In this report, we show that PLAG1 is a nuclear protein that binds DNA in a specific manner. The consensus PLAG1 binding site is a bipartite element containing a core sequence, GRGGC, and a G-cluster, RGGK, separated by seven random nucleotides. DNA binding is mediated mainly via three of the seven zinc fingers, with fingers 6 and 7 interacting with the core and finger 3 with the G-cluster. In transient transactivation assays, PLAG1 specifically activates transcription from its consensus DNA binding site, indicating that PLAG1 is a genuine transcription factor. Potential PLAG1 binding sites were found in the promoter 3 of the human insulin-like growth factor II (IGF-II) gene. We show that PLAG1 binds IGF-II promoter 3 and stimulates its activity. Moreover, IGF-II transcripts derived from the P3 promoter are highly expressed in salivary gland adenomas overexpressing PLAG1. In contrast, they are not detectable in adenomas without abnormal PLAG1 expression nor in normal salivary gland tissue. This indicates a perfect correlation between PLAG1 and IGF-II expression. All of these results strongly suggest that IGF-II is one of the PLAG1 target genes, providing us with the first clue for understanding the role of PLAG1 in salivary gland tumor development.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Voz, Marianne ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Agten, N. S.
Van de Ven, W. J.
Kas, K.
Language :
English
Title :
PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.
Publication date :
2000
Journal title :
Cancer Research
ISSN :
0008-5472
eISSN :
1538-7445
Publisher :
American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland
Kas, K., Voz, M. L., Roijer, E., Astrom, A. K., Meyen, E., Stenman, G., and Van de Ven, W. J. Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat. Genet., 15: 170-174, 1997.
Voz, M. L., Astrom, A. K., Kas, K., Mark, J., Stenman, G., and Van de Ven, W. J. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in up-regulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene, 16: 1409-1416, 1998.
Astrom, A. K., Voz, M. L., Kas, K., Roijer, E., Wedell, B., Mandahl, N., Van de Ven, W., Mark, J., and Stenman, G. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res., 59, 918-923, 1999.
Kas, K., Voz, M. L., Hensen, K., Meyen, E., and Van de Ven, W. J. M. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J. Biol. Chem., 273: 23026-23032, 1998.
Niwa, H., Yamamura, K., and Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (Amst.), 108: 193-199, 1991.
Van den Ouweland, A. M., Roebroek, A. J., Schalken, J. A., Claesen, C. A., Bloemers, H. P., and Van de Ven, W. J. Structure and nucleotide sequence of the 5′ region of the human and feline c-sis proto-oncogenes. Nucleic Acids Res., 14: 765-778, 1986.
Holthuizen, P. E., Cleutjens, C. B., Veenstra, G. J., van der Lee, F. M., KoonenReemst, A. M., and Sussenbach, J. S. Differential expression of the human, mouse and rat IGF-II genes. Regul. Pept., 48: 77-89, 1993.
van Dijk, M. A., van Schaik, F. M., Bootsma, H. J., Holthuizen, P., and Sussenbach, J. S. Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol., 81: 81-94, 1991.
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., and Barbacid, M. Transforming genes in human tumors. J. Cell. Biochem., 20: 51-61, 1982.
Jansen, E., Ayoubi, T. A., Meulemans, S. M., and Van de Ven, W. J. Regulation of human prohormone convertase 2 promoter activity by the transcription factor EGR-1. Biochem. J., 328: 69-74, 1997.
Goudet, G., Delhalle, S., Biemar, P., Martial, J. A., and Peers, B. Functional and cooperative interactions between the homeodomain PDX1, Pbx, and Prep1 factors on the somatostatin promoter. J. Biol. Chem., 274: 4067-4073, 1999.
Nordeen, S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques, 6: 454-458, 1988.
Dull, T. J., Gray, A., Hayflick, J. S., and Ullrich, A. Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature (Lond.), 310: 777-781, 1984.
Medema, R. H., Wubbolts, R., and Bos, J. L. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol. Cell. Biol., 11: 5963-5967, 1991.
van den Ouweland, A. M., Breuer, M. L., Steenbergh, P. H., Schalken, J. A., Bloemers, H. P., and Van de Ven, W. J. Comparative analysis of the human and feline c-sis proto-oncogenes. Identification of 5′ human c-sis coding sequences that are not homologous to the transforming gene of simian sarcoma virus. Biochim. Biophys. Acta., 825: 140-147, 1985.
Sadowski, I., Bell, B., Broad, P., and Hollis, M. GAL4 fusion vectors for expression in yeast or mammalian cells. Gene (Amst.), 118: 137-141, 1992.
Ikeda, K., and Kawakami, K. DNA binding through distinct domains of zinc-finger-tomeodomain protein AREB6 has different effects on gene transcription. Eur. J. Biochem., 233: 73-82, 1995.
Cavin Perier, R., Junier, T., and Bucher, P. The Eukaryotic Promoter Database EPD. Nucleic Acids Res., 26: 353-357, 1998.
van Dijk, M. A., Holthuizen, P. E., and Sussenbach, J. S. Elements required for activation of the major promoter of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol., 88: 175-185, 1992.
Roijer, E., Kas, K., Behrendt, M., Van de Ven, W., and Stenman, G. Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement. Genes Chromosomes Cancer, 24: 78-82, 1999.
Kas, K., Roijer, E., Voz, M., Meyen, E., Stenman, G., and Van de Ven, W. J. A 2-Mb YAC contig and physical map covering the chromosome 8q12 breakpoint cluster region in pleomorphic adenomas of the salivary glands. Genomics, 43: 349-358, 1997.
Choo, Y., and Klug, A. Selection of DNA binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc. Natl. Acad. Sci. USA, 91: 11168-11172, 1994.
Choo, Y., and Klug, A. Physical basis of a protein-DNA recognition code. Curr. Opin. Struct. Biol., 7: 117-125, 1997.
Abdollahi, A., Godwin, A. K., Miller, P. D., Getts, L. A., Schultz, D. C., Taguchi, T., Testa, J.R., and Hamilton, T. C. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res., 57: 2029-2034, 1997.
Abdollahi, A., Roberts, D., Godwin, A. K., Schultz, D. C., Sonoda, G., Testa, J. R., and Hamilton, T. C. Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors. Oncogene, 14: 1973-1979, 1997.
Spengler, D., Villalba, M., Hoffmann, A., Pantaloni, C., Houssami, S., Bockaert, J., and Journot, L. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J., 16: 2814-2825, 1997.
Varrault, A., Ciani, E., Apiou, F., Bilanges, B., Hoffmann, A., Pantaloni, C., Bockaert, J., Spengler, D., and Journot, L. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc. Natl. Acad. Sci. USA, 95: 8835-8840, 1998.
Toretsky, J. A., and Helman, L. J. Involvement of IGF-II in human cancer. J. Endocrinol., 149: 367-372, 1996.
El-Badry, O. M., Romanus, J. A., Helman, L. J., Cooper, M. J., Rechler, M. M., and Israel, M. A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Investig., 84: 829-839, 1989.
Daughaday, W. H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology, 127: 1-4, 1990.
Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J. d. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (Washington DC), 257: 674-678, 1992.
Devereux, J., Haeberli, P., and Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12: 387-395, 1984
Rauscher, F. J. d., Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
Bucher, P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol., 212: 563-578, 1990.
Christy, B., and Nathans, D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA, 86: 8737-8741, 1989.
